BioArctic AB (publ)
BRCTF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $17,882 | $24,014 | $26,556 | $22,226 |
| - Cash | $513 | $612 | $805 | $848 |
| + Debt | $54 | $5 | $10 | $16 |
| Enterprise Value | $17,423 | $23,407 | $25,760 | $21,393 |
| Revenue | $257 | $616 | $228 | $23 |
| % Growth | -58.2% | 169.8% | 886.3% | – |
| Gross Profit | $230 | $526 | $154 | -$32 |
| % Margin | 89.5% | 85.5% | 67.4% | -137.9% |
| EBITDA | -$211 | $295 | $4 | -$127 |
| % Margin | -82.1% | 47.9% | 1.8% | -546.8% |
| Net Income | -$177 | $229 | -$11 | -$120 |
| % Margin | -68.8% | 37.2% | -4.9% | -517.5% |
| EPS Diluted | -2 | 2.59 | -0.13 | -1.36 |
| % Growth | -177.2% | 2,092.3% | 90.4% | – |
| Operating Cash Flow | -$316 | $310 | -$32 | -$140 |
| Capital Expenditures | -$27 | -$7 | -$13 | -$4 |
| Free Cash Flow | -$343 | $302 | -$44 | -$145 |